EA201401212A1 - Производные пирролотриазинона - Google Patents

Производные пирролотриазинона

Info

Publication number
EA201401212A1
EA201401212A1 EA201401212A EA201401212A EA201401212A1 EA 201401212 A1 EA201401212 A1 EA 201401212A1 EA 201401212 A EA201401212 A EA 201401212A EA 201401212 A EA201401212 A EA 201401212A EA 201401212 A1 EA201401212 A1 EA 201401212A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pyrrolotriazinone
derivatives
diseases
tankyrase
parp
Prior art date
Application number
EA201401212A
Other languages
English (en)
Other versions
EA027628B1 (ru
Inventor
Дитер Дорш
Ханс-Петер Бухшталлер
Original Assignee
Мерк Патент Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Патент Гмбх filed Critical Мерк Патент Гмбх
Publication of EA201401212A1 publication Critical patent/EA201401212A1/ru
Publication of EA027628B1 publication Critical patent/EA027628B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)

Abstract

Соединения формулы Iв которой X, Rи Y имеют значения, указанные в п.1, являются ингибиторами танкиразы и PARP-1 и могут применяться, среди прочего, для лечения заболеваний, таких как злокачественное новообразование, сердечно-сосудистые заболевания, поражения центральной нервной системы и различные формы воспаления.
EA201401212A 2012-05-04 2013-04-06 Производные пирролотриазинона EA027628B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12003445 2012-05-04
PCT/EP2013/001026 WO2013164061A1 (en) 2012-05-04 2013-04-06 Pyrrolotriazinone derivatives

Publications (2)

Publication Number Publication Date
EA201401212A1 true EA201401212A1 (ru) 2015-08-31
EA027628B1 EA027628B1 (ru) 2017-08-31

Family

ID=48050660

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201401212A EA027628B1 (ru) 2012-05-04 2013-04-06 Производные пирролотриазинона

Country Status (22)

Country Link
US (1) US9174995B2 (ru)
EP (1) EP2844659B1 (ru)
JP (1) JP6097820B2 (ru)
KR (1) KR20150006873A (ru)
CN (1) CN104271580B (ru)
AR (1) AR090896A1 (ru)
AU (1) AU2013257018B2 (ru)
CA (1) CA2872334C (ru)
EA (1) EA027628B1 (ru)
ES (1) ES2587939T3 (ru)
HK (1) HK1205740A1 (ru)
HR (1) HRP20161033T1 (ru)
HU (1) HUE028325T2 (ru)
IL (1) IL235414A (ru)
MX (1) MX357502B (ru)
PL (1) PL2844659T3 (ru)
PT (1) PT2844659T (ru)
RS (1) RS55062B1 (ru)
SG (1) SG11201406997WA (ru)
SI (1) SI2844659T1 (ru)
WO (1) WO2013164061A1 (ru)
ZA (1) ZA201408876B (ru)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102104144B1 (ko) 2012-03-07 2020-04-23 디 인스티튜트 오브 캔서 리서치:로얄 캔서 하스피틀 3-아릴-5-치환-이소퀴놀린-1-온 화합물 및 그의 치료적 용도
EP3044221B1 (en) 2013-09-11 2018-02-21 Institute of Cancer Research: Royal Cancer Hospital (The) 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use
CA2934663A1 (en) * 2013-12-23 2015-07-02 Merck Patent Gmbh Imidazopyrazinone derivatives
UY36060A (es) 2014-04-02 2015-10-30 Bayer Pharma AG Compuestos de azol sustituidos con amida
WO2015154630A1 (zh) * 2014-04-10 2015-10-15 南京明德新药研发股份有限公司 作为PARP抑制剂的4H-吡唑并[1,5-α]苯并咪唑化合物的类似物
KR20160007347A (ko) 2014-07-11 2016-01-20 에스티팜 주식회사 신규한 이미다조트리아지논 또는 이미다조피라지논 유도체, 및 이들의 용도
KR101775356B1 (ko) * 2015-07-06 2017-09-06 재단법인 아산사회복지재단 Parp 및 탄키라제 동시 저해제에 대한 감수성 결정 방법
WO2017059191A1 (en) 2015-09-30 2017-04-06 Quartet Medicine, Inc. Heteroaryl derivatives as sepiapterin reductase inhibitors
WO2017055316A1 (en) 2015-10-01 2017-04-06 Bayer Pharma Aktiengesellschaft Amido-substituted azole compounds
WO2017055313A1 (en) 2015-10-01 2017-04-06 Bayer Pharma Aktiengesellschaft Amido-substituted azole compounds
US10570137B2 (en) 2015-11-16 2020-02-25 Topadur Pharma Ag 2-phenyl-3,4-dihydropyrrolo[2,1 -F] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof
US10722484B2 (en) 2016-03-09 2020-07-28 K-Gen, Inc. Methods of cancer treatment
WO2018078009A1 (en) 2016-10-29 2018-05-03 Bayer Pharma Aktiengesellschaft Amido-substituted cyclohexane derivatives
WO2018078005A1 (en) 2016-10-29 2018-05-03 Bayer Pharma Aktiengesellschaft Amido-substituted azaspiro derivatives as tankyrase inhibitors
WO2018087126A1 (en) 2016-11-09 2018-05-17 Bayer Pharma Aktiengesellschaft Amido-substituted cyclohexane derivatives as inhibitors of tankyrase
CN109180702B (zh) * 2018-10-29 2021-11-30 四川大学 一种噻吩并嘧啶酮化合物及其用途
CN111961058B (zh) * 2020-08-03 2022-12-16 天津全和诚科技有限责任公司 4-氨基-吡咯并三嗪衍生物及其制备方法和用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
DE69720965T2 (de) 1996-02-13 2004-02-05 Astrazeneca Ab Chinazolinderivate und deren verwendung als vegf hemmer
WO1997032856A1 (en) 1996-03-05 1997-09-12 Zeneca Limited 4-anilinoquinazoline derivatives
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
KR20030013433A (ko) 2000-05-31 2003-02-14 아스트라제네카 아베 혈관 손상 활성을 가진 인돌 유도체
CA2411160A1 (en) 2000-07-07 2002-01-17 Angiogene Pharmaceuticals Limited Colchinol derivatives as vascular damaging agents
JP2004504391A (ja) 2000-07-07 2004-02-12 アンギオジェン・ファーマシューティカルズ・リミテッド 血管新生阻害剤としてのコルキノール誘導体
WO2004087056A2 (en) 2003-03-28 2004-10-14 Scios Inc. BI-CYCLIC PYRIMIDINE INHIBITORS OF TGFβ
AU2005288858B2 (en) * 2004-09-30 2011-04-21 Janssen R&D Ireland HCV inhibiting bi-cyclic pyrimidines
WO2008092861A1 (en) * 2007-01-30 2008-08-07 Janssen Pharmaceutica N.V. Bicyclic derivatives as ep4 agonists
SI2134691T1 (sl) 2007-03-08 2012-06-29 Janssen Pharmaceutica Nv Derivati kvinolina kot PARP in TANK inhibitorji
CN101687874B (zh) * 2007-04-18 2013-01-30 百时美施贵宝公司 吡咯并三嗪激酶抑制剂

Also Published As

Publication number Publication date
WO2013164061A8 (en) 2014-11-06
AU2013257018B2 (en) 2017-02-16
PL2844659T3 (pl) 2016-11-30
EP2844659B1 (en) 2016-05-25
US20150133453A1 (en) 2015-05-14
MX357502B (es) 2018-07-12
CA2872334C (en) 2020-06-30
HUE028325T2 (en) 2016-12-28
HRP20161033T1 (hr) 2016-10-21
IL235414A (en) 2017-11-30
CA2872334A1 (en) 2013-11-07
KR20150006873A (ko) 2015-01-19
AR090896A1 (es) 2014-12-17
MX2014013090A (es) 2014-12-08
HK1205740A1 (en) 2015-12-24
RS55062B1 (sr) 2016-12-30
CN104271580B (zh) 2017-02-22
ZA201408876B (en) 2017-06-28
ES2587939T3 (es) 2016-10-27
SI2844659T1 (sl) 2016-10-28
SG11201406997WA (en) 2014-11-27
PT2844659T (pt) 2016-08-31
JP2015515961A (ja) 2015-06-04
AU2013257018A1 (en) 2014-12-18
US9174995B2 (en) 2015-11-03
JP6097820B2 (ja) 2017-03-15
CN104271580A (zh) 2015-01-07
WO2013164061A1 (en) 2013-11-07
EA027628B1 (ru) 2017-08-31
EP2844659A1 (en) 2015-03-11

Similar Documents

Publication Publication Date Title
EA201401212A1 (ru) Производные пирролотриазинона
EA201401062A1 (ru) Бициклические пиразиноновые производные
EA201400879A1 (ru) Производные тетрагидрохиназолинона в качестве ингибиторов tank и parp
EA201590230A1 (ru) Соединения пиразолопиримидина в качестве ингибиторов киназ
MX362939B (es) Derivados de (aza-)isoquinolinona.
EA201400333A1 (ru) Бензонитрильные производные в качестве ингибиторов киназ
EA201301302A1 (ru) Производные пиридина и пиразина
MX362855B (es) Derivados de quinazolinona como inhidores poli (adp-ribosa) polimerasa (parp).
NZ700928A (en) Dna-pk inhibitors
EA201301301A1 (ru) Производные тиазола
EA201492216A1 (ru) Ингибиторы бромодомена и их применение
MX362215B (es) Derivados 2-aminopirido-[4,3-d]pirimidin-5-ona y su uso como inhibidores de wee-1.
EA201291143A1 (ru) Пиразолилхиназолиновые ингибиторы киназы
EA201491623A1 (ru) Замещенные пирролидин-2-карбоксамиды
EA201300610A1 (ru) Хиназолинкарбоксамидазетидины
MX2016001136A (es) Derivados de oxoquinazolinil-butanamida.
EA201590552A1 (ru) Аминохинолины в качестве ингибиторов киназы
MX2016001134A (es) Derivados 1,3-disustituidos de ciclopentano.
EA201691177A1 (ru) Ингибиторы серин/треонинкиназ
MX364859B (es) Derivados de imidazopirazinona.
EA201590820A1 (ru) Производные 4-карбоксамидоизоиндолинона в качестве селективных ингибиторов parp-1
EA201200087A1 (ru) 2-карбоксамиды циклоаминомочевин, которые являются ингибиторами pi3k
MX366140B (es) Derivados de urea de piperidinas.
EA201491026A1 (ru) Производные 3-фенилизохинолин-1(2h)-она в качестве ингибиторов parp-1
EA201590656A1 (ru) Азаиндолины

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU